SHC PHARMACY LIMITED
SHC PHARMACY LIMITED
SHC PHARMACY LIMITED
Company Registration Number:
SC130669 (Scotland)
Unaudited statutory accounts for the year ended 31 March 2022
Period of accounts
Start date: 1 April 2021
End date: 31 March 2022
SHC PHARMACY LIMITED
Contents of the Financial Statements
for the Period Ended 31 March 2022
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes |
SHC PHARMACY LIMITED
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 March 2022
Additional information
The company was acquired by The M&D Green Group Limited on 31 January 2022. The trade and assets of the company were hived across to M&D Dispensing Chemist Limited, a fully owned subsidiary of The M&D Green Group Limited on 31 March 2022. From 1 April 2022, the Company ceased to trade and will shortly be wound up and struck off.
Directors
The director shown below has held office during the period of
1 April 2021 to 28 February 2022
The director shown below has held office during the period of
1 April 2021 to 31 January 2022
The director shown below has held office during the period of
31 January 2022 to 31 March 2022
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
SHC PHARMACY LIMITED
Profit And Loss Account
for the Period Ended
2022 | 2021 | |
---|---|---|
| £ | £ |
Turnover: | | |
Cost of sales: | ( | ( |
Gross profit(or loss): | | |
Administrative expenses: | ( | ( |
Other operating income: | | |
Operating profit(or loss): | | |
Interest payable and similar charges: | ( | ( |
Profit(or loss) before tax: | | |
Profit(or loss) for the financial year: | | |
SHC PHARMACY LIMITED
Balance sheet
As at
Notes | 2022 | 2021 | |
---|---|---|---|
| £ | £ | |
Fixed assets | |||
Tangible assets: | 3 | | |
Total fixed assets: | | | |
Creditors: amounts falling due within one year: | 6 | ( | |
Net current assets (liabilities): | | ||
Total assets less current liabilities: | | | |
Provision for liabilities: | ( | ||
Total net assets (liabilities): | | | |
Capital and reserves | |||
Called up share capital: | | | |
Profit and loss account: | ( | | |
Total Shareholders' funds: | | |
The notes form part of these financial statements
SHC PHARMACY LIMITED
Balance sheet statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
SHC PHARMACY LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2022
-
1. Accounting policies
Basis of measurement and preparation
These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102 Turnover policy
Turnover is recognised at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods or services to the customer net of discounts, VAT, and other sales-related taxes.Turnover from sale of goods is recognised when the risk and rewards of ownership of the goods have transferred to the buyer. Tangible fixed assets depreciation policy
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.Plant and machinery - 25% on costFixtures and fittings - 10% on costComputer Equipment - 25% on cost Other accounting policies
Going concern: From 1 April 2022, the company ceased trading and will shortly be wound up and struck off. Thus, the financial statements are prepared on a basis other than going concern.Stocks: Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.Financial instruments: Basic financial instruments are recognised at amortised cost.Taxation: Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.Current or deferred taxation assets and liabilities are not discounted.Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the the period end and that are expected to apply to the reversal of the timing difference.Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is profitable and they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.Hire purchase leasing commitments: Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.Pension costs and other post-retirement benefits: The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.
SHC PHARMACY LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2022
-
2. Employees
2022 2021 Average number of employees during the period 13 11
SHC PHARMACY LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2022
3. Tangible assets
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
At 1 April 2021 | | | | | ||
Additions | ||||||
Disposals | ( | ( | ( | ( | ||
Revaluations | ||||||
Transfers | ||||||
At 31 March 2022 | | | | | ||
Depreciation | ||||||
At 1 April 2021 | | | | | ||
Charge for year | | | | |||
On disposals | ( | ( | ( | ( | ||
Other adjustments | ||||||
At 31 March 2022 | | | | | ||
Net book value | ||||||
At 31 March 2022 | | | | | ||
At 31 March 2021 | | | | |
SHC PHARMACY LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2022
4. Stocks
2022 | 2021 | |
---|---|---|
£ | £ | |
Stocks | | |
Total | |
SHC PHARMACY LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2022
5. Debtors
2022 | 2021 | |
---|---|---|
£ | £ | |
Trade debtors | | |
Prepayments and accrued income | | |
Other debtors | | |
Total | |
SHC PHARMACY LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2022
6. Creditors: amounts falling due within one year note
2021 | ||
---|---|---|
£ | ||
Trade creditors | | |
Taxation and social security | | |
Accruals and deferred income | | |
Other creditors | | |
Total | |